Sue A. Yocum

2.0k citations

23 papers · 1.5k indexed · 1 hit paper · h-index 14

Rheumatology top 1%
- Osteoarthritis Treatment and Mechanisms 6
Cancer Research top 5%
- Protease and Inhibitor Mechanisms 10
Immunology and Allergy top 5%
- Cell Adhesion Molecules Research 3
Oncology top 10%
- Peptidase Inhibition and Analysis 10
Pharmacology top 5%
Molecular Biology
- Signaling Pathways in Disease 5
- Chemical Synthesis and Analysis 2
Organic Chemistry
- Carbohydrate Chemistry and Synthesis 3
Surgery
- Knee injuries and reconstruction techniques 2

Co-authors: Peter G. Mitchell Lori Lopresti‐Morrow Kieran F. Geoghegan Lucy Reeves John Hambor Peter A. Kiener Bruce Rankin Robert S. Mittler
Cited by: Rheumatology Cancer Research Immunology and Allergy
Partner nations: United States Netherlands

In The Last Decade

Sue A. Yocum

23 papers receiving 1.5k citations

Hit Papers

align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

1996 Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage.

Peers

Countries citing papers authored by Sue A. Yocum

Since Specialization

Citations

This map shows the geographic impact of Sue A. Yocum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sue A. Yocum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sue A. Yocum more than expected).

Fields of papers citing papers by Sue A. Yocum

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sue A. Yocum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sue A. Yocum. The network helps show where Sue A. Yocum may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Sue A. Yocum, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sue A. Yocum Line = papers co-authored together Sue A. Yocum links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	IGFBP-5 Metabolism Is Disrupted in the Rat Medial Meniscal Tear Model of Osteoarthritis Matthew Yates,Steven L. Settle,Sue A. Yocum,Poonam Aggarwal,Lillian Vickery,Dean J. Aguiar,Adam Skepner,Debra Kellner,Scott L. Weinrich,Francis M. Sverdrup	2010	6
2	Octahydrophenanthrene-2,7-diol Analogues as Dissociated Glucocorticoid Receptor Agonists: Discovery and Lead Exploration Ralph P. Robinson,Leonard Buckbinder,A.I. Haugeto,Patricia A. McNiff,Michele L. Millham,Matthew R. Reese,Jean F. Schaefer,Yuriy A. Abramov,Jon Bordner,Yves Chantigny,Edward F. Kleinman,Ellen R. Laird,B. Paul Morgan,John C. Murray,E.D. Salter,Matthew D. Wessel,Sue A. Yocum	2009	36
3	The canine bilateral groove model of osteoarthritis F. Intema,Jeroen DeGroot,Bram Elshof,Marieke E. Vianen,Sue A. Yocum,Anne‐Marie Zuurmond,S.C. Mastbergen,Floris P. J. G. Lafeber	2008	13
4	Complement 1s is the serine protease that cleaves IGFBP-5 in human osteoarthritic joint fluid Walker H. Busby,Sue A. Yocum,Michael A. Rowland,Debra Kellner,S. Lazerwith,Francis M. Sverdrup,M. Yates,M. Radabaugh,David R. Clemmons	2008	13
5	Discovery of 3,3-dimethyl-5-hydroxypipecolic hydroxamate-based inhibitors of aggrecanase and MMP-13 Mark C. Noe,Vijayalakshmi Natarajan,Sheri L. Snow,Peter G. Mitchell,Lori Lopresti‐Morrow,Lisa M. Reeves,Sue A. Yocum,Thomas J. Carty,John A. Barberia,Francis J. Sweeney,Jennifer L. Liras,Marcie Vaughn,Joel R. Hardink,Joel M. Hawkins,Christopher J. Tokar	2005	29
6	Discovery of 3-OH-3-methylpipecolic hydroxamates: Potent orally active inhibitors of aggrecanase and MMP-13 Mark C. Noe,Vijayalakshmi Natarajan,Sheri L. Snow,Lilli A. Wolf‐Gouveia,Peter G. Mitchell,Lori Lopresti‐Morrow,Lisa M. Reeves,Sue A. Yocum,Ivan G. Otterness,Marcia A. Bliven,Thomas J. Carty,John T. Barberia,Francis J. Sweeney,Jennifer L. Liras,Marcie Vaughn	2005	26
7	3-Hydroxy-4-arylsulfonyltetrahydropyranyl-3-hydroxamic acids are novel inhibitors of MMP-13 and aggrecanase Mark C. Noe,Sheri L. Snow,Lilli A. Wolf‐Gouveia,Peter G. Mitchell,Lori Lopresti‐Morrow,Lisa M. Reeves,Sue A. Yocum,Jennifer L. Liras,Marcie Vaughn	2004	12
8	Phosphinic acid-based MMP-13 inhibitors that spare MMP-1 and MMP-3 Lawrence A. Reiter,Peter G. Mitchell,Gary J. Martinelli,Lori Lopresti‐Morrow,Sue A. Yocum,James D. Eskra	2003	27
9	Design and synthesis of 2-oxo-imidazolidine-4-carboxylic acid hydroxyamides as potent matrix metalloproteinase-13 inhibitors Ralph P. Robinson,Ellen R. Laird,Kathleen M. Donahue,Lori Lopresti‐Morrow,Peter G. Mitchell,Matthew R Reese,Lisa M. Reeves,Amber I. Rouch,Ethan J. Stam,Sue A. Yocum	2001	18
10	Structure-Based Design and Synthesis of a Potent Matrix Metalloproteinase-13 Inhibitor Based on a Pyrrolidinone Scaffold Ralph P. Robinson,Ellen R. Laird,James F. Blake,Jon Bordner,Kathleen M. Donahue,Lori Lopresti‐Morrow,Peter G. Mitchell,Matthew R. Reese,Lisa M. Reeves,Ethan J. Stam,Sue A. Yocum	2000	30
11	Inhibition of MMP-1 and MMP-13 with phosphinic acids that exploit binding in the S2 pocket Lawrence A. Reiter,James P. Rizzi,Jayvardhan Pandit,Michael J. Lasut,Shunda M. McGahee,Vinod D. Parikh,James F. Blake,Dennis E. Danley,Ellen R. Laird,Arturo Lopez‐Anaya,Lori Lopresti‐Morrow,Mahmoud N. Mansour,Gary J. Martinelli,Peter G. Mitchell,Brian S. Owens,Thomas Pauly,Lisa M. Reeves,Gayle K. Schulte,Sue A. Yocum	1999	31
12	MMP‐13 and MMP‐1 Expression in Tissues of Normal Articular Joints Sue A. Yocum,Lori Lopresti‐Morrow,Lisa M. Reeves,Peter G. Mitchell	1999	11
13	Cloning of the gene for interstitial collagenase-3 (matrix metalloproteinase-13) from rabbit synovial fibroblasts: differential expression with collagenase-1 (matrix metalloproteinase-1) Matthew P. Vincenti,Charles I. Coon,John A. Mengshol,Sue A. Yocum,Peter G. Mitchell,Constance Brinckerhoff	1998	78
14	Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage.breakdown → Peter G. Mitchell,Holly A. Magna,Lucy Reeves,Lori Lopresti‐Morrow,Sue A. Yocum,Philip J. Rosner,Kieran F. Geoghegan,John Hambor	1996	806
15	Inhibitors of MMP-1: an examination of P1′ Cα gem-disubstitution in the succinamide hydroxamate series Ralph P. Robinson,John A. Ragan,Brian J. Cronin,Kathleen M. Donahue,Lori Lopresti‐Morrow,Peter G. Mitchell,Lisa M. Reeves,Sue A. Yocum	1996	7
16	Bafilomycin A1 Inhibits IL-1-Stimulated Proteoglycan Degradation by Chondrocytes Without Affecting Stromelysin Synthesis Sue A. Yocum,Lori Lopresti‐Morrow,Christopher A. Gabel,Anthony J. Milici,Peter G. Mitchell	1995	22
17	Immune Complexes of LDL Induce Atherogenic Responses in Human Monocytic Cells Peter A. Kiener,Bruce Rankin,Patricia M. Davis,Sue A. Yocum,Glenn A. Warr,Robert I. Grove	1995	45
18	Inhibition of Interleukin‐1—Stimulated Collagen Degradation in Cartilage Explants Peter G. Mitchell,Lori Lopresti‐Morrow,Sue A. Yocum,Francis J. Sweeney,Lawrence A. Reiter	1994	3
19	Stimulation of tyrosine phosphorylation and calcium mobilization by Fc gamma receptor cross-linking. Regulation by the phosphotyrosine phosphatase CD45 Bruce Rankin,Sue A. Yocum,Robert S. Mittler,Peter A. Kiener	1993	78
20	Coordinate occupancy of AP-1 sites in the vitamin D-responsive and CCAAT box elements by Fos-Jun in the osteocalcin gene: model for phenotype suppression of transcription. Thomas A. Owen,Rita Bortell,Sue A. Yocum,Steven L. Smock,M Zhang,C Abate,Victoria Shalhoub,Neil Aronin,Kenneth L. Wright,André J. van Wijnen	1990	169

About Sue A. Yocum

Sue A. Yocum is a scholar working on Anatomy, Cancer Research and Immunology and Allergy, having authored 23 papers that have together received 1.5k indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (10 papers), Protease and Inhibitor Mechanisms (10 papers), Osteoarthritis Treatment and Mechanisms (6 papers), Signaling Pathways in Disease (5 papers), Carbohydrate Chemistry and Synthesis (3 papers), Cell Adhesion Molecules Research (3 papers), Chemical Synthesis and Analysis (2 papers) and Knee injuries and reconstruction techniques (2 papers). The work is most often cited by research in Rheumatology (623 citations), Cancer Research (620 citations) and Immunology and Allergy (182 citations). Sue A. Yocum has collaborated with scholars based in United States and Netherlands. Frequent co-authors include Peter G. Mitchell, Lori Lopresti‐Morrow, Kieran F. Geoghegan, Lucy Reeves, John Hambor, Peter A. Kiener, Bruce Rankin, Robert S. Mittler, Neil Aronin and André J. van Wijnen.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact